Type of Program:
Grant / Investment
CQDM’s Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members.
Comments on Funding:
Funding may consist in a grant or an investment.
Requested funds must range from $500,000 to $1,200,000. Exceptionally, CQDM may consider applications exceeding the maximum, if appropriate.
Applicants are responsible for raising matched funding for the project.
When It Ends:
February 24th, 2022
fill out the Quantum Leap pharma-led funding program for drug discovery research application form;
email the completed form at any time to email@example.com;
submit a revised application, if required, including any additional information required and addressing comments, concerns and questions issued by the interested pharmaceutical members and/or CQDM’s Scientific Advisory Board.
Other Things to Note:
- 1CQDM is a biopharmaceutical research consortium that funds innovation. They bring together world-class pharmaceutical corporations, several Canadian biotech companies, the best scientists from both the public and private sectors, as well as the Canadian and Quebec governments.
- 2Call for proposals are open year-round for Quantum Leap projects. Deadline to participate in the next selection round: February 24th, 2022